With half of chronically ill patients failing to take medication correctly, Oska Health secures €11 million for personal health app

February 26, 2026 at 12:52 PM UTC
EU-Startups
Original: EN
With half of chronically ill patients failing to take medication correctly, Oska Health secures €11 million for personal health app

European healthtech is experiencing a significant surge in investment, with companies leveraging digital solutions and AI to manage chronic conditions more effectively. Oska Health, a Frankfurt-based hybrid care provider, recently secured €11 million in Seed funding to scale its continuous care model for chronically ill patients. This capital infusion highlights a broader trend of digital care platforms attracting early-stage funding across Europe, aiming to bridge gaps in long-term condition management. Oska Health's innovative approach combines personal health coaches with AI-powered technology. This hybrid model supports coaches, reduces administrative burdens, and aims to make high-quality chronic care scalable and economically sustainable. The platform focuses on multimorbid patients, those with multiple chronic diseases like diabetes and hypertension, by translating physician recommendations into everyday lifestyle and dietary changes. This is crucial as approximately half of chronically ill patients struggle with correct medication adherence, leading to complications and hospitalizations. This investment round reflects a wider European HealthTech trend where digital care platforms are gaining traction. Similar to Oska Health, companies like Holi, Doctor.One, and Annette have raised substantial funds to expand their digital treatment platforms and asynchronous care models for chronic conditions. These investments underscore investor confidence in digital solutions that improve health outcomes between clinical visits, bolstering the European digital health ecosystem and addressing significant challenges within healthcare systems.

Curated and translated by Europe Digital for our multilingual European audience.

Source Information

Publication: EU-Startups
Published: February 26, 2026 at 12:52 PM UTC
All rights remain with the original publisher.